| Patents for A61P 33 - Antiparasitic agents (21,787) |
|---|
| 09/03/2003 | EP1339715A2 Heterocyclic ether substituted imidazoquinolines |
| 09/03/2003 | EP1339709A1 Farnesyl transferase inhibiting benzoheterocyclic derivatives |
| 09/03/2003 | EP1339708A2 Indole-type inhibitors of p38 kinase |
| 09/03/2003 | EP1339679A1 3-arylindole derivatives and their use as cb2 receptor agonists |
| 09/03/2003 | EP1339668A2 Bisubstituted carbocyclic cyclophilin binding compounds and theirus |
| 09/03/2003 | EP1339427A2 Method of producing biospecific molecules by protein trans-splicing |
| 09/03/2003 | EP1339400A1 Hydroxamic acid or n-formyl hydroxylamine derivatives as inhibitors of bacterial polypeptide deformylase for treating microbial infections |
| 09/03/2003 | CN1440289A Anthelmintic agents for preventing parasitic infections in humans and animals Ôàó" |
| 09/03/2003 | CN1440285A Anthelminthic agents for prevention of parasitic infections in humans and animals |
| 09/03/2003 | CN1440280A Anthelminthic agents for prevention of parasitic infections in humans and animals Ôàí" |
| 09/03/2003 | CN1439428A Medical use and medicinal preparation of trichonema in preventing human and animals from diseases by immunologic inadequacy |
| 09/03/2003 | CN1120156C N,N'-bis (quinolin-4-yl-diamine derive and their preparation and their use as antimalarials |
| 09/02/2003 | US6614694 Erase scheme for non-volatile memory |
| 09/02/2003 | US6613783 Non-systemic control of parasites |
| 08/28/2003 | WO2003070921A1 METHODS FOR PRODUCING Ϝδ T CELLS |
| 08/28/2003 | WO2003070242A1 Piperidin-4-yl urea derivatives and related compounds as chemokine receptor inhibitors for the treatment of inflammatory diseases |
| 08/28/2003 | WO2003070220A1 Ph-sensitive cationic lipids, and liposomes and nanocapsules containing the same |
| 08/28/2003 | WO2003070192A2 Compositions and methods for surrogate antibody modulation of an immune response and transport |
| 08/28/2003 | WO2003070190A2 Surrogate antibodies and methods of preparation and use thereof |
| 08/28/2003 | WO2003069997A1 Immunostimulant compositions comprising aminoalkyl glucosaminide phosphates and saponins |
| 08/28/2003 | WO2002083063A3 Method of improving systemic exposure of subcutaneously administered therapeutic proteins |
| 08/28/2003 | WO2002078603A3 Plasmodium falciparum erythrocyte binding protein baebl for use as a vaccine |
| 08/28/2003 | WO2002036627A3 Interferons, uses and compositions related thereto |
| 08/28/2003 | WO2002000839A3 Statement as to federally sponsored research |
| 08/28/2003 | US20030162808 Acetindine derivatives, their preparation and medicaments containing them |
| 08/28/2003 | US20030162748 Comprises liposomes attached to prodrugs through phosphonate linkages; phospholipases; targets liver/spleen |
| 08/28/2003 | US20030162730 Crystal forms of azithromycin |
| 08/28/2003 | US20030162223 Detection of insecticide; determination, calibration of binding to protein |
| 08/28/2003 | US20030162175 NK cell receptor polynucleotides, polypeptides, and antibodies |
| 08/28/2003 | US20030161838 A highly purified protein, Plasmodium falciparum MSP-142, which retains folding and disulfide bridging of the native molecule and is useful as a diagnostic reagent, antibody production, and as a vaccine for malaria |
| 08/28/2003 | US20030161834 Adjuvant compositions comprising a saponin and and an immunostimulatory oligonucleotide containing unmethylated CpG (a cytosine guanosine dinucleotide DNA motif); synergistic induction of antigen; anticarcinogenic agents |
| 08/28/2003 | US20030161809 Complexes; drug delivery |
| 08/28/2003 | CA2477191A1 Immunostimulant compositions comprising aminoalkyl glucosaminide phosphates and saponins |
| 08/28/2003 | CA2476854A1 Surrogate antibodies and methods of preparation and use thereof |
| 08/28/2003 | CA2476764A1 Compositions and methods for surrogate antibody modulation of an immune response and transport |
| 08/28/2003 | CA2475437A1 Methods for producing .gamma..delta. t cells |
| 08/28/2003 | CA2473089A1 Piperidin-4-yl urea derivatives and related compounds as chemokine receptor inhibitors for the treatment of inflammatory diseases |
| 08/27/2003 | EP1338599A1 Optically pure analogues of Camptothecin |
| 08/27/2003 | EP1337641A2 Flea gaba receptor subunit nucleic acid molecules, proteins and uses thereof |
| 08/27/2003 | EP1337544A2 Polynucleotide encoding an activated human t-lymphocyte-derived protein related to ubiquitin conjugating enzyme |
| 08/27/2003 | EP1337510A2 Synthesis and antimicrobial activityof novel dicationic "reversed amidines" |
| 08/27/2003 | EP1337274A2 Hydroxyapatite-targeting poly(ethylene glycol) and related polymers |
| 08/27/2003 | EP1259244B1 Veterinary compositions for the treatment of parasitic diseases |
| 08/27/2003 | EP0946567B1 Novel counterparts of camptothecin, their application as medicine and pharmaceutical compositions containing them |
| 08/27/2003 | CN1438896A Vaccine comprising a tick cement protein |
| 08/27/2003 | CN1438891A Nucleoside analogs with carboxamidine wodified monocyclic base |
| 08/27/2003 | CN1438884A Therapeutic combinations of fatty acids |
| 08/27/2003 | CN1438879A Endoparasiticidal composition for voluntary oral ingestion by animals |
| 08/27/2003 | CN1119149C 10,11 methanodibenzosuberane derivatives used as chemo sensitizing agents |
| 08/26/2003 | US6610332 Antiprotozoa agents; plant extracts |
| 08/26/2003 | US6610320 Mixture of cocoa plant extract and antichloesterol agent |
| 08/26/2003 | US6610298 Molecular conjugate comprising (a) a photosensitizer and (b) a targeting moiety, wherein the targeting moiety targets the conjugate to the intracellular pathogen or to an infected host cell. |
| 08/21/2003 | WO2003068955A2 Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins |
| 08/21/2003 | WO2003068747A1 Nicotinamide derivates useful as p38 inhibitors |
| 08/21/2003 | WO2003068270A1 Method of radio-labelling biomolecules |
| 08/21/2003 | WO2003068234A1 Nicotinamide derivatives and a tiotropium salt in combination for the treatment of e.g. inflammatory, allergic and respiratory diseases |
| 08/21/2003 | WO2003068232A1 Nicotinamide derivatives useful as pde4 inhibitors |
| 08/21/2003 | WO2003068230A1 Substituted pyridinones as modulators of p38 map kinase |
| 08/21/2003 | WO2003068228A1 Aryl ureas with angiogenesis inhibiting activity |
| 08/21/2003 | WO2003068169A2 Stabilized synthetic immunogen delivery system |
| 08/21/2003 | WO2003055913A3 Secreted protein |
| 08/21/2003 | WO2003024404A3 Chemokines as adjuvants of immune response |
| 08/21/2003 | WO2003007930A3 Use of sulfonyl aryl or heteroaryl hydroxamic acids and derivatives thereof as aggrecanase inhibitors |
| 08/21/2003 | WO2002057452A3 Human proteins, polynucleotides encoding them and methods of using the same |
| 08/21/2003 | WO2002044209A3 Cytonkine receptor zcytor19 |
| 08/21/2003 | WO2001097753A3 Novel methods using pyridine derivatives |
| 08/21/2003 | US20030158260 Halogenated N-phenyl-N'-benzoylurea derivatives for controlling a sea lice infestation on fish; e.g., 1-(4-chloro-3-(3-chloro-5-trifluoro-methyl-2-pyridyloxy)-phenyl)-3-(2,6 -difluorobenzoyl)urea |
| 08/21/2003 | US20030158243 Preparation and use of carbohydrate-based bicyclic ring structures with antimicrobial and cytostatic activity |
| 08/21/2003 | US20030158204 Diamino phenothiazine derivatives and composition comprising same |
| 08/21/2003 | US20030158192 Activating cytokine biosynthesis, viricides treating a viral disease, antitumor agents, immunomodulators |
| 08/21/2003 | US20030157160 Vaccine for modulating between T1 and T2 immune responses |
| 08/21/2003 | US20030157135 Enhancement and/or extension of antigen-specific Th1-type responses, in particular, CD8+ T cell responses; for treatment of various infectious and neoplastic diseases |
| 08/21/2003 | CA2475708A1 Nicotinamide derivatives useful as pde4 inhibitors |
| 08/21/2003 | CA2475703A1 Aryl ureas with angiogenesis inhibiting activity |
| 08/21/2003 | CA2475522A1 Method of radio-labelling biomolecules |
| 08/21/2003 | CA2475102A1 Stabilized synthetic immunogen delivery systems |
| 08/20/2003 | EP1336608A1 Dibenzosberanyl piperazine derivatives and drug-resistance overcoming agents containing the derivatives |
| 08/20/2003 | EP1335935A1 Periplasmic domain of an enterobacterium omp protein and its use as carrier or adjuvant |
| 08/20/2003 | EP1335899A2 Substituted alkyldiamines as inhibitors of plasmepsin or related proteases |
| 08/20/2003 | EP1212327B1 Pyrazolopyrimidines as therapeutic agents |
| 08/20/2003 | EP1086106B1 Furopyridine derivatives and their therapeutical use |
| 08/20/2003 | EP0765313B1 N,n'-bis(quinolin-4-yl)-diamine derivatives, their preparation and their use as antimalarials |
| 08/19/2003 | US6608192 Collections of compounds |
| 08/19/2003 | US6608077 Il-8 receptor antagonists |
| 08/19/2003 | US6608035 Orally administering to mammal oligonucleotide of 15 to 30 nucleotides, comprising phosphorothioate linkages between nucleosides and 2'-O-alkoxyalkyl-ribonucleotides at each end, whereby oligonucleotide is intact in liver and kidney tissue |
| 08/19/2003 | US6608033 Treatment or prevention of coccidiosis |
| 08/19/2003 | US6607728 Compounds and methods for the diagnosis and treatment of ehrlichia infection |
| 08/14/2003 | WO2003066807A2 Method of inhibiting pathogenicity of infectious agents |
| 08/14/2003 | WO2003066806A2 Therapeutic use of aziridino compounds |
| 08/14/2003 | WO2003066649A1 Immunostimulatory, covalently lipidated oligonucleotides |
| 08/14/2003 | WO2003066077A2 Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (nmu1) |
| 08/14/2003 | WO2003066065A1 Prophylactic and therapeutic treatment of infectious and other diseases with immunoeffector compounds |
| 08/14/2003 | WO2003066003A2 Anti-pathogen treatements |
| 08/14/2003 | WO2003065991A2 N-substituted3-hydroxy-4-pyridinones and pharmaceuticals containing thereof |
| 08/14/2003 | WO2003065871A2 Methods and compositions for treating hematological disorders |
| 08/14/2003 | WO2003056909A3 Hair removal and animal husbandry method |
| 08/14/2003 | WO2003047617A3 Vaccine |
| 08/14/2003 | WO2003037335A8 5-heteroatom-substituted pyrazoles |
| 08/14/2003 | WO2002064083A3 Synthesis of 3-amino-thalidomide and its enantiomers |
| 08/14/2003 | WO2002057453A3 Polypetides and nucleic acids encoding same |